Overview

Targeted Fusion Biopsy of the Prostate

Status:
Completed

Trial end date:
2018-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if using Positron Emission Tomography (PET) scan and transrectal ultrasound (TRUS) guided biopsy together (creating a 3-dimensional ultrasound) will detect prostate cancer more accurately than the standard 2-dimensional approach which uses only the TRUS to guide the biopsy.

Phase:

Phase 2

Details

Lead Sponsor:

Emory University

Collaborator:

National Cancer Institute (NCI)